Press Releases

SEC Filing Details

Document Details

Form
Filing Date
Feb 25, 2022
Document Date
Feb 24, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Entasis Therapeutics Holdings Inc.
Issuer
ENTASIS THERAPEUTICS HOLDINGS INC.
Filer
WAGNER KRISTIE ANN